(Q53458751)

14 May 2018

title

Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. (English)

1 reference

14 May 2018

author name string

M Takahashi

1

1 reference

14 May 2018

M Fukutake

2

1 reference

14 May 2018

S Yokota

3

1 reference

14 May 2018

K Ishida

4

1 reference

14 May 2018

K Wakabayashi

5

1 reference

14 May 2018

T Sugimura

6

1 reference

14 May 2018

publication date

1 January 1996

1 reference

14 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

14 May 2018

volume

122

1 reference

14 May 2018

issue

4

1 reference

14 May 2018

page(s)

219-222

1 reference

14 May 2018

Altered eicosanoid levels in human colon cancer

cites work

1 reference

12 December 2020

Perspectives on cancer in Japan and the United States.

1 reference

12 December 2020

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

12 December 2020

Identification and quantification of aberrant crypt foci and microadenomas in the human colon

1 reference

12 December 2020

Aberrant crypts: putative preneoplastic foci in human colonic mucosa.

1 reference

12 December 2020

Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds

1 reference

12 December 2020

Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors

1 reference

12 December 2020

A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats

1 reference

12 December 2020

Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use.

1 reference

12 December 2020

Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents

1 reference

12 December 2020

Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

1 reference

12 December 2020

1 reference

12 December 2020

Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

1 reference

12 December 2020

Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer

1 reference

12 December 2020

Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid.

1 reference

12 December 2020

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

1 reference

12 December 2020

Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine.

1 reference

12 December 2020

Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester

1 reference

12 December 2020

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1 reference

12 December 2020

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

12 December 2020

Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods

1 reference

12 December 2020

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

1 reference

12 December 2020

Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

1 reference

12 December 2020

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

1 reference

12 December 2020

Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings

1 reference

12 December 2020

Aspirin use and reduced risk of fatal colon cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01209649

1 reference

14 May 2018

1 reference

14 May 2018